KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $2.12.

  • Johnson & Johnson's EPS (Basic) rose 4929.58% to $2.12 in Q4 2025 from the same period last year, while for Dec 2025 it was $11.13, marking a year-over-year increase of 9058.22%. This contributed to the annual value of $11.13 for FY2025, which is 9058.22% up from last year.
  • As of Q4 2025, Johnson & Johnson's EPS (Basic) stood at $2.12, which was up 4929.58% from $2.14 recorded in Q3 2025.
  • Johnson & Johnson's 5-year EPS (Basic) high stood at $10.32 for Q4 2023, and its period low was -$0.19 during Q2 2023.
  • Its 5-year average for EPS (Basic) is $1.97, with a median of $1.76 in 2022.
  • In the last 5 years, Johnson & Johnson's EPS (Basic) crashed by 12935.3% in 2023 and then soared by 443442.17% in 2024.
  • Johnson & Johnson's EPS (Basic) (Quarter) stood at $1.39 in 2021, then rose by 22.3% to $1.7 in 2022, then crashed by 101.93% to -$0.03 in 2023, then skyrocketed by 4434.42% to $1.42 in 2024, then skyrocketed by 49.3% to $2.12 in 2025.
  • Its EPS (Basic) was $2.12 in Q4 2025, compared to $2.14 in Q3 2025 and $2.3 in Q2 2025.